Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NFκB-mediated transcription pathway is a crucial cellular signaling cascade that regulates the activity of the NF-κB family of transcription factors. It controls gene expression in response to various stimuli, including inflammatory signals, stress, cytokines, free radicals, and pathogens. Activation leads to the translocation of NF-κB dimers into the nucleus, where they bind DNA and regulate the transcription of genes involved in inflammation, immunity, cell survival, and proliferation. Dysregulation of this pathway is implicated in cancer and chronic inflammatory diseases.
Varies depending on the specific drug; examples include inhibition of IKK, inhibition of proteasomal degradation of IκB, inhibition of NF-κB DNA binding, and reduction of upstream activating signals.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated transcription pathway (NF-κB pathway).